ESSA Pharma Inc. (EPIX)

AI Score

Unlock

1.48

-0.10 (-6.33%)

At close: Apr 04, 2025, 3:59 PM

1.46

-1.35%

After-hours: Apr 04, 2025, 04:55 PM EDT

ESSA Pharma Income Statement

Chart Mode

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016	FY 2015	FY 2014	FY 2013	FY 2012
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016	Sep 30, 2015	Sep 30, 2014	Sep 30, 2013	Dec 31, 2012
Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	217.00	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	118.49K	121.79K	109.46K	110.32K	n/a	34.49K	46.15K	66.18K	n/a	n/a	n/a	n/a
Gross Profit	n/a	-118.49K	-121.79K	-109.46K	-110.32K	n/a	-34.49K	-46.15K	-65.96K	n/a	n/a	n/a	n/a
Operating Income	n/a	-32.13M	-35.34M	-36.91M	-23.12M	-12.15M	-10.8M	-11.65M	-19.64M	-9.31M	-1.82M	-1.36M	-1.94K
Interest Income	n/a	5.55M	1.74M	235K	559.72K	26.25K	42.73K	n/a	n/a	618.25	217.00	1.31K	1.42
Pretax Income	n/a	-26.58M	-35.22M	-36.84M	-23.73M	-10.4M	-11.6M	-4.38M	-12.99M	-8.57M	-1.82M	-1.37M	-1.94K
Net Income	n/a	-26.58M	-35.1M	-36.81M	-23.45M	-10.44M	-11.63M	-4.5M	-13.14M	-8.57M	-1.82M	-1.37M	-1.94K
Selling & General & Admin	n/a	10.81M	12.54M	12.78M	11.37M	5.47M	5.93M	5.14M	5.64M	3.7M	1.04M	371.18K	298.27
Research & Development	21.21M	21.32M	24.41M	24.26M	12.15M	6.7M	4.87M	5.73M	13.06M	4.39M	671.6K	1.59M	1.76K
Other Expenses	n/a	n/a	1.74M	109.46K	515K	35K	-40K	-37K	79K	1.15M	n/a	n/a	n/a
Operating Expenses	21.21M	32.13M	36.96M	37.14M	23.52M	12.17M	10.8M	10.87M	18.7M	9.23M	1.74M	1.37M	1.94K
Interest Expense	n/a	6.94K	14K	22.22K	618K	603K	912K	785K	938K	77.77K	87.59K	n/a	n/a
Selling & Marketing Expenses	n/a	22.57K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	21.83K	22.96
Cost & Expenses	n/a	32.13M	36.96M	37.14M	23.52M	12.17M	10.8M	10.87M	18.7M	9.23M	1.74M	1.37M	1.94K
Income Tax Expense	n/a	1.6K	-112K	-34.35K	-289K	38K	27K	116K	151K	77.77K	87.59K	0.28	n/a
Shares Outstanding (Basic)	44.28M	44.09M	44.04M	38.48M	22.44M	8.43M	4.57M	1.45M	1.35M	917.65K	784.38K	784K	732.00
Shares Outstanding (Diluted)	44.28M	44.09M	44.04M	38.48M	22.44M	8.43M	4.57M	1.45M	1.35M	917.65K	784.38K	784.38K	732.65
EPS (Basic)	-0.64	-0.6	-0.8	-0.96	-1.04	-1.24	-2.55	-3.09	-9.77	-9.34	-2.33	-1.75	-2.65
EPS (Diluted)	-0.64	-0.6	-0.8	-0.96	-1.04	-1.24	-2.55	-3.09	-9.77	-9.34	-2.33	-1.75	-2.65
EBITDA	n/a	-26.46M	-35.08M	-36.71M	-23.01M	-12.13M	-10.77M	-3.55M	-18.67M	-9.38M	-1.76M	-1.34M	-1.91K
EBIT	n/a	-26.57M	-35.2M	-36.82M	-23.12M	-12.15M	-10.69M	-3.6M	-18.73M	-9.42M	-1.78M	-1.36M	n/a
Depreciation & Amortization	n/a	118.49K	121.79K	109.46K	110.32K	18.3K	34.49K	46.15K	66.18K	39.1K	23.39K	24.62K	25.41